ImmunityBio Inc (IBRX)
3.055
+0.18
(+6.45%)
USD |
NASDAQ |
Dec 16, 16:00
3.08
+0.02
(+0.82%)
After-Hours: 20:00
ImmunityBio Total Liabilities (Quarterly): 1.109B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Q32 Bio Inc | 86.25M |
| HCA Healthcare Inc | 58.67B |
| Biomarin Pharmaceutical Inc | 1.438B |
| Incyte Corp | 1.841B |
| Insmed Inc | 1.570B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 364.57M |
| Shareholders Equity (Quarterly) | -745.15M |
| Debt to Equity Ratio | -0.9382 |
| Current Ratio | 2.676 |
| Net Debt Paydown Yield | 0.54% |